H Hoogendoorn

1.2k total citations
32 papers, 918 citations indexed

About

H Hoogendoorn is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, H Hoogendoorn has authored 32 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Critical Care and Intensive Care Medicine. Recurrent topics in H Hoogendoorn's work include Blood Coagulation and Thrombosis Mechanisms (17 papers), Blood properties and coagulation (8 papers) and Platelet Disorders and Treatments (7 papers). H Hoogendoorn is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (17 papers), Blood properties and coagulation (8 papers) and Platelet Disorders and Treatments (7 papers). H Hoogendoorn collaborates with scholars based in Canada, United States and Netherlands. H Hoogendoorn's co-authors include AR Giles, Alan R. Giles, Lesley Mitchell, Patricia Vegh, M Andrew, Michael E. Nesheim, ME Nesheim, Kenneth G. Mann, Paula B. Tracy and Georges‐Étienne Rivard and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Neurology.

In The Last Decade

H Hoogendoorn

32 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Hoogendoorn Canada 16 620 145 135 111 109 32 918
J. Reynaud France 15 465 0.8× 152 1.0× 110 0.8× 131 1.2× 122 1.1× 34 768
Barry White Ireland 14 421 0.7× 142 1.0× 53 0.4× 78 0.7× 125 1.1× 22 807
G Scapoli Italy 14 271 0.4× 115 0.8× 49 0.4× 160 1.4× 130 1.2× 37 716
Jonathan T. Wilde United Kingdom 15 634 1.0× 140 1.0× 130 1.0× 147 1.3× 173 1.6× 23 993
Hideo Wada Japan 13 251 0.4× 105 0.7× 109 0.8× 99 0.9× 57 0.5× 32 698
J Fehr Switzerland 10 322 0.5× 134 0.9× 59 0.4× 96 0.9× 51 0.5× 27 698
Janine Campbell Australia 14 206 0.3× 126 0.9× 56 0.4× 81 0.7× 106 1.0× 23 652
Miho Sakakura Japan 15 315 0.5× 47 0.3× 71 0.5× 101 0.9× 48 0.4× 35 680
C. M. Schambeck Germany 13 233 0.4× 150 1.0× 50 0.4× 56 0.5× 71 0.7× 26 452
Clemens Feistritzer United States 11 717 1.2× 116 0.8× 64 0.5× 240 2.2× 118 1.1× 13 1.0k

Countries citing papers authored by H Hoogendoorn

Since Specialization
Citations

This map shows the geographic impact of H Hoogendoorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Hoogendoorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Hoogendoorn more than expected).

Fields of papers citing papers by H Hoogendoorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Hoogendoorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Hoogendoorn. The network helps show where H Hoogendoorn may publish in the future.

Co-authorship network of co-authors of H Hoogendoorn

This figure shows the co-authorship network connecting the top 25 collaborators of H Hoogendoorn. A scholar is included among the top collaborators of H Hoogendoorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Hoogendoorn. H Hoogendoorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taneja, Ravi, Leslie R. Berry, Larry Stitt, et al.. (2014). Protamine Requirements in Cardiac Surgery: Effect of Changes in the Heparin Reference Standard. Journal of Cardiothoracic and Vascular Anesthesia. 28(5). 1227–1232. 8 indexed citations
2.
3.
Nielsen, Vance G., et al.. (2007). Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics. Blood Coagulation & Fibrinolysis. 18(2). 145–150. 34 indexed citations
4.
VOSSEN, C.Y., Sandra J. Hasstedt, Frits R. Rosendaal, et al.. (2004). Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C‐deficient family. Journal of Thrombosis and Haemostasis. 2(2). 242–247. 61 indexed citations
5.
Hatton, Mark W.C., et al.. (1999). Uptake of heparin cofactor II and antithrombin into the aorta wall after a deendothelializing injury in vivo: Comparison with the behaviors of prothrombin and fibrinogen. Journal of Laboratory and Clinical Medicine. 133(1). 81–87. 6 indexed citations
6.
Hatton, M.W.C., et al.. (1997). Comparative metabolism and distribution of rabbit heparin cofactor II and rabbit antithrombin in rabbits. American Journal of Physiology-Endocrinology and Metabolism. 272(5). E824–E831. 8 indexed citations
7.
Mitchell, Lesley, H Hoogendoorn, AR Giles, Patricia Vegh, & M Andrew. (1994). Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency. Blood. 83(2). 386–391. 168 indexed citations
8.
9.
10.
Hoogendoorn, H, Cheng‐Hong Toh, ME Nesheim, & AR Giles. (1991). Alpha 2-macroglobulin binds and inhibits activated protein C. Blood. 78(9). 2283–2290. 1 indexed citations
11.
Giles, Alan R., et al.. (1990). The Fibrinolytic Potential of the Normal Primate following the Generation of Thrombin In Vivo. Thrombosis and Haemostasis. 63(3). 476–481. 51 indexed citations
12.
Hoogendoorn, H, ME Nesheim, & AR Giles. (1990). A qualitative and quantitative analysis of the activation and inactivation of protein C in vivo in a primate model. Blood. 75(11). 2164–2171. 37 indexed citations
13.
Giles, AR, et al.. (1988). In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency). Blood. 72(1). 335–339. 36 indexed citations
14.
Kisilevsky, Robert, et al.. (1988). A reproducible model for the study of factor X kinetics in AA amyloidosis. Experimental and Molecular Pathology. 48(3). 419–426. 1 indexed citations
15.
Giles, Alan R., et al.. (1987). Type IIB von Willebrand's disease presenting as thrombocytopenia during pregnancy. British Journal of Haematology. 67(3). 349–353. 14 indexed citations
16.
Giles, Alan R., H Hoogendoorn, & Shawn Tinlin. (1984). The thrombogenicity of prothrombin complex concentrates. IV. The source of coagulant-active phospholipid. Thrombosis Research. 34(6). 567–572. 4 indexed citations
17.
Giles, Alan R., Michael E. Nesheim, H Hoogendoorn, Paula B. Tracy, & Kenneth G. Mann. (1982). Stroma free human platelet lysates potentiate the in vivo thrombogenicity of factor Xa by the provision of coagulant‐active phospholipid. British Journal of Haematology. 51(3). 457–468. 9 indexed citations
18.
Giles, Alan R., H Hoogendoorn, & M. A. Blajchman. (1981). The thrombogenicity of prothrombin complex concentrates: III. The relationship of thrombogenicity to the nature of the starting plasma. Thrombosis Research. 21(3). 255–263. 10 indexed citations
19.
Giles, AR, H Hoogendoorn, M.A. Blajchman, & J. Hirsh. (1980). The thrombogenicity of prothrombin complex concentrates: II. The effect of thrombocytopenia on in vivo thrombogenicity in rabbits. Thrombosis Research. 17(3-4). 555–560. 6 indexed citations
20.
Hoogendoorn, H, A.L. Cerskus, Frederick A. Ofosu, M. A. Blajchman, & J. Hirsh. (1980). Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatography. Thrombosis Research. 20(1). 77–83. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Reynaud Breakdown of academic impact, for papers by Barry White Breakdown of academic impact, for papers by G Scapoli Breakdown of academic impact, for papers by Jonathan T. Wilde Breakdown of academic impact, for papers by Hideo Wada Breakdown of academic impact, for papers by J Fehr Breakdown of academic impact, for papers by Janine Campbell Breakdown of academic impact, for papers by Miho Sakakura Breakdown of academic impact, for papers by C. M. Schambeck Breakdown of academic impact, for papers by Clemens Feistritzer
Rankless by CCL
2026